Infection Complications in 476 Patients with Newly Diagnosed Multiple Myeloma Treated with Lenalidomide or Bortezomib Combinations

被引：0
|
作者：
Offidani, Massimo [1 ]
Corvatta, Laura [2 ]
Bringhen, Sara [3 ]
Gentili, Silvia [4 ]
Gay, Francesca [3 ]
Maracci, Laura [4 ]
Boccadoro, Mario [3 ]
Leoni, Pietro [4 ]
Palumbo, Antonio [3 ]
机构：
[1] Osped Riuniti Ancona, Haematol Clin, Ancona, Italy
[2] Osped Stelluti Fabriano, Internal Med, Fabriano, Italy
[3] AOU San Giovanni Battista Torino Osped Molinette, Div Hematol, Turin, Italy
[4] ADD Osped Riuniti Ancona, Clin Ematol, Ancona, Italy
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] A comparison of lenalidomide/dexamethasone versus cyclophosphamide/lenalidomide/dexamethasone versus cyclophosphamide/bortezomib/dexamethasone in newly diagnosed multiple myeloma
    Khan, Meaghan L.
    Reeder, Craig B.
    Kumar, Shaji K.
    Lacy, Marthy Q.
    Reece, Donna E.
    Dispenzieri, Angela
    Gertz, Morie A.
    Greipp, Phillip
    Hayman, Suzanne
    Zeldenhurst, Steven
    Dingli, David
    Lust, John
    Russell, Stephen
    Laumann, Kristina M.
    Mikhael, Joseph R.
    Bergsagel, P. Leif
    Fonseca, Rafael
    Rajkumar, S. Vincent
    Stewart, A. Keith
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (03) : 326 - 333
  • [32] The Choice Of Regimens Based On Bortezomib For Patients With Newly Diagnosed Multiple Myeloma
    Yang, Li
    He, Jingsong
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    [J]. BLOOD, 2013, 122 (21)
  • [33] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Tan, Carlyn Rose
    Derkach, Andriy
    Nemirovsky, David
    Ciardiello, Amanda
    Diamond, Benjamin
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi
    Maclachlan, Kylee
    Patel, Dhwani
    Lahoud, Oscar B. B.
    Landau, Heather J. J.
    Chung, David J. J.
    Shah, Gunjan L. L.
    Scordo, Michael
    Giralt, Sergio A. A.
    Lesokhin, Alexander
    Usmani, Saad Z. Z.
    Landgren, Ola
    Korde, Neha
    [J]. BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [34] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Carlyn Rose Tan
    Andriy Derkach
    David Nemirovsky
    Amanda Ciardiello
    Benjamin Diamond
    Malin Hultcrantz
    Hani Hassoun
    Sham Mailankody
    Urvi Shah
    Kylee Maclachlan
    Dhwani Patel
    Oscar B. Lahoud
    Heather J. Landau
    David J. Chung
    Gunjan L. Shah
    Michael Scordo
    Sergio A. Giralt
    Alexander Lesokhin
    Saad Z. Usmani
    Ola Landgren
    Neha Korde
    [J]. Blood Cancer Journal, 13
  • [35] Evaluation of a Generic Bortezomib Molecule in Newly Diagnosed Multiple Myeloma Patients
    Mersin, Sinan
    Geduk, Ayfer
    Mehtap, Ozgur
    Tarkun, Pinar
    Unal, Serkan
    Polat, Merve Gokcen
    Aygun, Kemal
    Yenihayat, Emel Merve
    Albayrak, Hayrunnisa
    Hacihanifioglu, Abdullah
    [J]. TURKISH JOURNAL OF HEMATOLOGY, 2021, 38 (03) : 211 - 217
  • [36] Ixazomib combined with lenalidomide and dexamethasone chemotherapy for newly diagnosed multiple myeloma in China-Compared with bortezomib/lenalidomide/dexamethasone
    Huo, Zhongjun
    Chen, Fang
    Liu, Ping
    Luo, Zimian
    [J]. CANCER MEDICINE, 2023, 12 (03): : 2937 - 2944
  • [37] Combination Therapy Based on Bortezomib for Newly Diagnosed Multiple Myeloma Patients
    He, Jingsong
    Yang, Li
    Jin, Dian
    Lin, Xuanru
    Yang, Qianqian
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Zhang, Jie
    Lin, Maofang
    Huang, He
    Cai, Zhen
    [J]. BLOOD, 2012, 120 (21)
  • [38] COMBINATION THERAPY BASED ON BORTEZOMIB FOR PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
    Cai, C.
    He, J.
    Yang, Y.
    Han, H.
    Zheng, G.
    Zheng, W.
    Wei, W.
    Wu, W.
    Ye, Y.
    Shi, S.
    Xie, X.
    Li, L.
    Zhang, Z.
    Huang, H.
    Huang, H.
    Zhen, Z.
    [J]. HAEMATOLOGICA, 2012, 97 : 611 - 611
  • [39] The Choice of Regimens Based on Bortezomib for Patients with Newly Diagnosed Multiple Myeloma
    He, Jingsong
    Yang, Li
    Han, Xiaoyan
    Zheng, Gaofeng
    Zheng, Weiyan
    Wei, Guoqing
    Wu, Wenjun
    Ye, Xiujin
    Shi, Jimin
    Xie, Wanzhuo
    Li, Li
    Zhang, Jie
    Huang, Weijia
    Zhao, Yi
    Huang, He
    Zhang, Xuejin
    Fu, Jiaping
    Cai, Zhen
    [J]. PLOS ONE, 2014, 9 (06):
  • [40] Efficacy and safety analysis of bortezomib-based triplet regimens sequential lenalidomide in newly diagnosed multiple myeloma patients
    Zhou, Qiaolin
    Xu, Fang
    Wen, Jingjing
    Yue, Jing
    Zhang, Ya
    Su, Jing
    Liu, Yiping
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1573 - 1580
12345